Surveillance for multidrug-resistant Acinetobacter baumannii: A lesson on definitions

International Journal of Antimicrobial Agents

Volumn 36, Issue 5, 2010, Pages 469-471

  Ho, Pak Leung ^a   Ho, Alex Y ^a   Chow, Kin Hung ^a   Cheng, Vincent C C ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE DERIVATIVE; BACTERIAL ENZYME; CARBAPENEM; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULPERAZON; TIMENTIN;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ANTIBIOTIC RESISTANCE; BACTERIUM ISOLATE; BIOSURVEILLANCE; CHINA; CROSS RESISTANCE; DISK DIFFUSION; HOSPITAL ADMISSION; HUMAN; INCIDENCE; LETTER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; VANCOMYCIN RESISTANT ENTEROCOCCUS;

EID: 77957684005     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2010.07.004     Document Type: Letter

References (7)

1. Falagas M.E., Karageorgopoulos D.E. Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among Gram-negative bacilli: need for international harmonization in terminology. Clin Infect Dis 2008, 46:1121-1122. author reply 1122.
2. Falagas M.E., Koletsi P.K., Bliziotis I.A. The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa. J Med Microbiol 2006, 55:1619-1629.
3. Clinical and Laboratory Standards Institute. Analysis and presentation of cumulative antimicrobial susceptibility test data: approved guideline. Document M39-P. Wayne, PA: CLSI; 2005.
4. Ho P.L., Ho A.Y., Chow K.H., Lai E.L., Ching P., Seto W.H. Epidemiology and clonality of multidrug-resistant Acinetobacter baumannii from a healthcare region in Hong Kong. J Hosp Infect 2010, 74:358-364.
5. Maragakis L.L., Perl T.M. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis 2008, 46:1254-1263.
6. Institute of Medicine. Workshop report. In: Harrison PF, Lederberg J, editors. Antimicrobial resistance: issues and options. Washington, DC: National Academy Press; 1998. p. 8-74.
7. Collignon P., Powers J.H., Chiller T.M., Aidara-Kane A., Aarestrup F.M. World Health Organization ranking of antimicrobials according to their importance in human medicine: a critical step for developing risk management strategies for the use of antimicrobials in food production animals. Clin Infect Dis 2009, 49:132-141.